XML 107 R92.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders’ Deficit - Co-Founder Grants (Details)
shares in Millions, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2017
tranche
shares
Dec. 31, 2021
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Allocated share-based compensation expense | $     $ 346.5 $ 338.0 $ 330.7
Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares granted (in shares)     20.6   22.2
Vesting period     4 years    
Awards vesting (in shares)     0.0    
Restricted Stock | Co-Founder Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expiration period 10 years        
Number of tranches | tranche 9        
Trading period 30 days        
Allocated share-based compensation expense | $     $ 2.4 $ 9.4  
Remaining unamortized stock-based compensation | $     $ 0.0    
Restricted Stock | Co-Founder Grant | Tranche One          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period 4 years        
Restricted Stock | Co-Founder Grant | Tranche One | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage vested maximum 20.00%        
Chief Executive Officer | Restricted Stock | Co-Founder Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares granted (in shares) 10.3        
Awards vesting (in shares)   2.1